Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina

NCT00518921 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00518921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00518921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2008
Completion date
November 30, 2008
Enrollment
0 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable angina